Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A DNA methylation signature for the prediction of tumour recurrence in stage II colorectal cancer

24 Feb 2023

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Colorectal Cancer Surgical Treatments
Share to Epigenetics and DNA Methylation

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 36828869
DOI: 10.1038/s41416-023-02155-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A DNA methylation signature for the prediction of tumour recurrence in stage II colorectal cancerPMID 36828869Read ↗

A novel epigenetic signature to predict recurrence-free survival in patients with colon cancerSemantic proximity Read ↗

Identifying a Risk Signature of Methylation-Driven Genes as a Predictor of Survival Outcome for Colon Cancer PatientsSemantic proximity Read ↗

A panel of DNA methylation signature from peripheral blood may predict colorectal cancer susceptibilitySemantic proximity Read ↗

Clinical Applications of DNA Methylation Biomarkers in Colorectal CancerSemantic proximity Read ↗

Potential of DNA methylation in rectal cancer as diagnostic and prognostic biomarkersSemantic proximity Read ↗

A panel of DNA methylation signature from peripheral blood may predict colorectal cancer susceptibility.Semantic proximity Read ↗

Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.Semantic proximity Read ↗

Novel Genetic and Epigenetic Biomarkers of Prognostic and Predictive Significance in Stage II/III Colorectal CancerSemantic proximity Read ↗

Identification of Predictive DNA Methylation Biomarkers for Chemotherapy Response in Colorectal CancerSemantic proximity Read ↗

DNA methylation profile in CpG-depleted regions uncovers a high-risk subtype of early-stage colorectal cancerSemantic proximity Read ↗

Novel Methylation Biomarkers for Colorectal Cancer PrognosisSemantic proximity Read ↗

Molecular Classification of Colorectal Cancer Using Gene Expression Profile of Tumor SamplesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.